In the dynamic landscape of healthcare, Abbott Laboratories (NYSE: NYSE:ABT ) stands out with its robust first-quarter performance, showcasing resilience and adaptability amidst challenging conditions. Bolstered by a surge in medical device sales and buoyed by promising growth across multiple sectors, Abbott has exceeded expectations and raised its annual...
Wyckoff in place on ABT, I'm expecting the price reaching my supply zone in grey by doing an UTAD (second liquidation) and the continue the bearish trend.
Upside risk (5.23%)
Downside profit (50%)
ABT just broke out of a downtrend while simultaneously battling a key resistance zone. It did so, while gaining positive momentum within a monthly TTM squeeze (and firing the Daily Squeeze). If it can hold above the newly formed support, it might be ready for a bullish run up to its previous all-time-high, which is coincidentally equidistant from the newly...
NYSE:ABT Has formed a bearish impulse with a healthy correction and a lower degree impulse with a lower degree correction that is breaking out of the larger degree trend line!
This is great confirmation of a trend continuation setup.
Since the retracement is deep though, 78.6%, the trend continuation impulse could be short lived and reverse, or continue down side.
Abbott Laboratories ( NYSE:ABT ) recently reported earnings that slightly missed expectations at the midpoint, causing a 3.3% dip in NYSE:ABT stock to $110.21. However, a closer look at the results reveals a more nuanced story. Despite the earnings guidance falling short by three pennies at $4.60 per share for the year, the health care giant remains resilient,...
If you haven`t sold the regional top on ABT:
Nor reentered this fantastic dip:
Then analyzing the options chain and the chart patterns of ABT Abbott Laboratories prior to the earnings report this week,
I would consider purchasing the 115usd strike price at the money Calls with
an expiration date of 2024-2-16,
for a premium of approximately $2.26.
The chart is...
Hi Traders!
Let's take a look at ABT 4 hours chart. The price has formed the inverted Head & Shoulders pattern. We expect the price to rise up to a previous resistance line. Long position can be taken when the price breaks the neckline.
Stop loss is at $91.05
What do you think? Let us know in the comments!
M15, M30, and H1 are overbought, and there is a pattern for M15 to sell. This trade is with the H4 and Daily trend so it should go all the way to the bottom. There are many signs to sell this trade, and there is very good resistance at this level, stop loss above 100 should be good.
If you haven`t bought ABT here:
or sold it here:
Then analyzing the options chain and the chart patterns of ABT Abbott Laboratories prior to the earnings report this week,
I would consider purchasing the 91usd strike price Calls with
an expiration date of 2023-10-27,
for a premium of approximately $3.15.
If these options prove to be profitable prior to the...
Abbott Laboratories - 30d expiry - We look to Buy at 104.11 (stop at 100.91)
The trend of higher lows is located at 104.
The primary trend remains bullish.
This stock has seen good sales growth.
104 continues to hold back the bears.
Although the bears are in control, the stalling negative momentum indicates a turnaround is possible.
Our profit targets will...
ABT is trading at a fantastic level and is in an uptrend on the long-term chart. We can construct a position in this company with a risk-reward ratio of 1:1 or 1:2. At this point, it appears to be pretty nice.
